Back to Search
ANTHONY BORAL, M.D.
M.D.
Medical Oncology Physician
NPI: 1851452551Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
150057(MA)
Research & Publications (13)
Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180.
PMID 19506160·J Clin Oncol·2009
3-trial
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.
PMID 19170677·Br J Haematol·2009
3-trial
Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study.
PMID 19074748·Ann Oncol·2009
3-trial
The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma.
PMID 18673366·Br J Haematol·2008
8-other
Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study.
PMID 18200040·Leukemia·2008
3-trial
Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial.
PMID 17690257·Blood·2007
3-trial
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib.
PMID 17185464·Blood·2007
3-trial
Bortezomib-induced tumor lysis syndrome in multiple myeloma.
PMID 17229340·Clin Lymphoma Myeloma·2006
3-trial
Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.
PMID 17001068·J Clin Oncol·2006
3-trial
Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response?
PMID 16882131·Br J Haematol·2006
3-trial
Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity.
PMID 16606971·J Clin Oncol·2006
3-trial
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.
PMID 15958804·N Engl J Med·2005
3-trial
A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer.
PMID 11751486·Clin Cancer Res·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- MILLENNIUM PHARM., 40 LANDSDOWNE ST.
CAMBRIDGE, MA 02139 - Phone
- (617) 444-1351
Quick Facts
- NPI
- 1851452551
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 13
Are you this provider?
Claim Your Profile